Ministry of Food and Drug Safety Blocks and Takes Action on 359 Cases of Illegal Online Sales of GLP-1 Obesity Treatment Drugs

News Healthcare & Pharma Sanctions & Fines

Date: 21st Nov, 2024 Source: Korea Food and Drug Administration (KFDA) Country: South Korea Original Source

Brief

"On 21/11/2024, the Korea Food and Drug Administration (KFDA) issued an update regarding Ministry of Food and Drug Safety Blocks and Takes Action on 359 Cases of Illegal Online Sales of GLP-1 Obesity Treatment Drugs. The online sales were found to be in violation of the "Pharmaceuticals Act" and potential counterfeit or adulterated products posed safety risks, emphasizing that these medications should only be obtained from hospitals or pharmacies with a prescription."

This content is restricted.

Highlights content goes here...

This content is restricted.

Korea Food and Drug Administration (KFDA)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Ministry of Food and Drug Safety Blocks and Takes Action on 359 Cases of Illegal Online Sales of GLP-1 Obesity Treatment Drugs

Brief

Korea Food and Drug Administration (KFDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Ministry of Food and Drug Safety Blocks and Takes Action on 359 Cases of Illegal Online Sales of GLP-1 Obesity Treatment Drugs

Brief

Korea Food and Drug Administration (KFDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.